Public Calendar: January 19-25, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
Event Date: 01/23/2020
Location: Silver Spring, MD
Subject: Reagan-Udall Foundation Board of Directors Meeting: Introductions
FDA Participant/Group: DENISE HINTON; JACQUELINE CORRIGAN CURAY; ROBIN MCKINNON; DIANE MALONEY;
Non FDA Participant/Group: Several members of the Reagan-Udall Foundation Board
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
No Significant Event
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
No Significant Event
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 01/22/2020
Location: Washington, DC
Subject: Pharmaceutical Research and Manufacturers of America (PhRMA) Global Regulatory Leadership Dinner
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Keynote Address: Stem Cell Therapy Product Development - What’s on the Horizon for 2020
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia
Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Speaker: Making Use of the Regenerative Medicine Regulatory Toolkit
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia
Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Speaker: Encouraging Legitimate Research and Compliance – a Q&A with the Regulator
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia
Event Date: 01/22/2020
Location: Miami, FL
Subject: World Stem Cell Summit; Panel Discussion: Recent Advances on Regenerative Medicine Advanced Therapy (RMAT) and Tissue Rapid Inquiry Program (TRIP)
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from government, industry and academia
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 01/21/2020
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: AMBER MCCOIG; TIMOTHY SCHELL; SIOBHAN DELANCEY; JANICE STEINSCHNEIDER; WILLIAM FLYNN; NICOLE PEPPERL;
Non FDA Participant/Group: Alliance for Pharmacy Compounding representatives
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event